Skin Neoplasms

• 

  Subject Areas on Research

  • "Thin" malignant melanoma: risk factors and clinical management. 
  • 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. 
  • 18F-FDG PET/CT and Melanoma: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management. 
  • 4-Nitroquinoline-1-oxide-induced mutagen sensitivity and risk of nonmelanoma skin cancer: a case-control analysis. 
  • 4-nitroquinoline-1-oxide-induced mutagen sensitivity and risk of cutaneous melanoma: a case-control analysis. 
  • A CASE OF HIGH-RISK CILIARY BODY MELANOMA ARISING IN AN EYE AFTER RESECTION OF AN IRIDOCILIARY MELANOCYTOMA. 
  • A Case of Multiple Hemorrhagic Friable Nodules. 
  • A Hybrid Approach to Radiation-Induced Axillary Artery Hemorrhage. 
  • A PGC1β genetic variant associated with nevus count and melanoma mortality. 
  • A comparison of dermatologists' and primary care physicians' accuracy in diagnosing melanoma: a systematic review. 
  • A comprehensive genome-wide analysis of melanoma Breslow thickness identifies interaction between CDC42 and SCIN genetic variants. 
  • A germline mutation at the extreme 3' end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor. 
  • A locus for cerebral cavernous malformations maps to chromosome 7q in two families. 
  • A mechanism-based antioxidant approach for the reduction of skin carcinogenesis. 
  • A model for pretest probability of lymph node metastasis from cutaneous Melanoma. 
  • A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant. 
  • A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US. 
  • A multi-institutional experience of repeat regional chemotherapy for recurrent melanoma of extremities. 
  • A multicenter phase I dose escalation trial to evaluate safety and tolerability of intra-arterial temozolomide for patients with advanced extremity melanoma using normothermic isolated limb infusion. 
  • A multicenter prospective evaluation of the clinical utility of F-18 FDG-PET/CT in patients with AJCC stage IIIB or IIIC extremity melanoma. 
  • A multidisciplinary approach to toxicity management of modern immune checkpoint inhibitors in cancer therapy. 
  • A multiphase immunotherapy regimen for human melanoma: clinical and laboratory results. 
  • A novel mechanism of skin tumor promotion involving interferon-gamma (IFNγ)/signal transducer and activator of transcription-1 (Stat1) signaling. 
  • A patient with newly diagnosed melanoma and pulmonary nodules. 
  • A phase 1 study of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with locally advanced in-transit malignant melanoma. 
  • A phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma. 
  • A phase I multi-institutional study of systemic sorafenib in conjunction with regional melphalan for in-transit melanoma of the extremity. 
  • A phase I trial of recombinant human interleukin-1 beta (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation. 
  • A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides. 
  • A pilot trial of digital imaging in skin cancer. 
  • A prospective evaluation of the incidence of complications associated with Mohs micrographic surgery. 
  • A rationale for the treatment of difficult basal cell and squamous cell carcinomas of the skin. 
  • A retrospective cohort study of comprehensive peripheral and deep margin assessment in Merkel cell carcinoma: Standard margins may be unreliable. 
  • A surgical oncology perspective on AIDS. 
  • A systematic review of clinical outcomes for patients diagnosed with skin cancer spinal metastases. 
  • A topical antioxidant solution containing vitamins C and E stabilized by ferulic acid provides protection for human skin against damage caused by ultraviolet irradiation. 
  • A trichogenic tumor with aggressive features initially diagnosed as basal cell carcinoma. 
  • A video-based educational pilot for basal cell carcinoma (BCC) treatment: A randomized controlled trial. 
  • ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck. 
  • AIDS-associated Kaposi's sarcoma: variables associated with survival. 
  • AJR teaching file: incidental breast cancer detected with 18F-FDG PET/CT. 
  • AKT1 gene mutation levels are correlated with the type of dermatologic lesions in patients with Proteus syndrome. 
  • ASO Author Reflections: Adjuvant Therapy is Effective for Melanoma Patients with Positive Sentinel Lymph Node Biopsy Who Forgo Completion Lymphadenectomy. 
  • ASO Visual Abstract: An Internally Validated Prognostic Risk Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma. 
  • Abnormalities of circulating T-cell subpopulations in patients with cutaneous T-cell lymphoma: cutaneous lymphocyte-associated antigen expression on T cells correlates with extent of disease. 
  • Absence of estrogen receptor in human melanoma as evaluated by a monoclonal antiestrogen receptor antibody. 
  • Absence of the CAAX endoprotease Rce1: effects on cell growth and transformation. 
  • Accurate identification of proliferative index in melanocytic neoplasms with Melan-A/Ki-67 double stain. 
  • Acquired cutaneous smooth muscle hamartoma. 
  • Acral Melanomas of the Sole May Have Worse Prognosis Compared with Other Sites of Acral Melanoma. 
  • Acral melanoma: a review of 185 patients with identification of prognostic variables. 
  • Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2). 
  • Active-specific immunization against melanoma: is the problem at the receiving end? 
  • Activin enhances skin tumourigenesis and malignant progression by inducing a pro-tumourigenic immune cell response. 
  • Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology. 
  • Addressing the knowledge gap in clinical recommendations for management and complete excision of clinically atypical nevi/dysplastic nevi: Pigmented Lesion Subcommittee consensus statement. 
  • Adjuvant Radiation Therapy for Clinical Stage III Melanoma in the Modern Therapeutic Era. 
  • Adjuvant Therapy is Effective for Melanoma Patients with a Positive Sentinel Lymph Node Biopsy Who Forego Completion Lymphadenectomy. 
  • Adjuvant radiation therapy increases disease-free survival in stage IB Merkel cell carcinoma. 
  • Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial. 
  • Adult and Pediatric Nail Unit Melanoma: Epidemiology, Diagnosis, and Treatment. 
  • Advances in the care of the patient with malignant melanoma. 
  • Age and Breslow depth are associated with a positive sentinel lymph node in patients with cutaneous melanocytic tumors of uncertain malignant potential. 
  • Age as a prognostic factor in the malignant melanoma population. 
  • Aggressive digital papillary adenocarcinoma: treatment with Mohs micrographic surgery and an update of the literature. 
  • An Internally Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma. 
  • An acrochordon-like melanoma metastasis. 
  • An immunohistochemical comparison of cytokeratin 7, cytokeratin 15, cytokeratin 19, CAM 5.2, carcinoembryonic antigen, and nestin in differentiating porocarcinoma from squamous cell carcinoma. 
  • An intervention to decrease adolescent indoor tanning: a multi-method pilot study. 
  • An uncommon presentation of non-Hodgkin's lymphoma in a renal transplant recipient. 
  • Analysis of 945 cases of pulmonary metastatic melanoma. 
  • Analysis of clinical and serologic predictors of response to extracorporeal photopheresis therapy in cutaneous T-cell lymphoma patients. 
  • Analysis of prognosis and disease progression after local recurrence of melanoma. 
  • Analyzing the cost of preventing nonmelanoma skin cancer. 
  • Anaplastic lymphoma kinase (ALK1) immunohistochemistry in diagnostic dermatopathology; an update. 
  • Angiokeratoma of Fordyce. 
  • Antenatal ultrasonographic diagnosis of abdominal wall hemangioma: potential to simulate ventral abdominal wall defects. 
  • Application of posterior neck dissection in treating malignant melanoma of the posterior scalp. 
  • Are en face frozen sections accurate for diagnosing margin status in melanocytic lesions? 
  • Assessment of immunological techniques in the diagnosis and prognosis of ocular malignant melanoma. 
  • Association Between Cancer Center Accreditation and Compliance With Price Disclosure of Common Oncologic Surgical Procedures. 
  • Association between functional polymorphisms in genes involved in the MAPK signaling pathways and cutaneous melanoma risk. 
  • Association of Common Genetic Polymorphisms with Melanoma Patient IL-12p40 Blood Levels, Risk, and Outcomes. 
  • Association of Patient Proximity to Dermatologic Care With Melanoma Stage at Diagnosis and Outcome. 
  • Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus"). 
  • Augmentation of tumor-specific immunity by upregulation of apoptotic melanoma cell calreticulin expression. 
  • Autoantibodies against cell surface GRP78 promote tumor growth in a murine model of melanoma. 
  • Autosomal dominant multiple cylindromas associated with solitary lung cylindroma. 
  • BCAT1 and miR-2504: novel methylome signature distinguishes spindle/desmoplastic melanoma from superficial malignant peripheral nerve sheath tumor. 
  • Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. 
  • Basal cell carcinoma of the umbilicus: a case report and literature review. 
  • Basal cell carcinoma originating from a nevus sebaceus on the scalp of a 7-year-old boy. 
  • Baseline quality of life and anxiety in solid organ transplant recipients: a pilot study. 
  • Bayesian latent variable models for mixed discrete outcomes. 
  • Benefits to patient care of electronically capturing patient-reported outcomes in dermatology. 
  • Benign nodal nevi frequently harbor the activating V600E BRAF mutation. 
  • Bilateral total corneal and conjunctival choristomas associated with epidermal nevus. 
  • Blastic Plasmacytoid Dendritic Cell Neoplasm: Progress in Cell Origin, Molecular Biology, Diagnostic Criteria and Therapeutic Approaches. 
  • Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review. 
  • Brain Metastases From Melanoma: Therapy at the Crossroads. 
  • Bringing an end to the "Mongolian Spot". 
  • Burden of disease predicts response to isolated limb infusion with melphalan and actinomycin D in melanoma. 
  • CD10 expression in trichoepithelioma and basal cell carcinoma. 
  • CD34 expression in desmoplastic melanoma. 
  • CD4+/CD56+ hematodermic neoplasm: presentation of 2 cases and review of the concept of an uncommon tumor originated in plasmacytoid dendritic cells expressing CD123 (IL-3 receptor alpha). 
  • CD4/CD8 double negative pagetoid reticulosis: a case report and literature review. 
  • CDK2 activation in mouse epidermis induces keratinocyte proliferation but does not affect skin tumor development. 
  • CNS mycosis fungoides: CT and MR findings. 
  • CYLD inhibits melanoma growth and progression through suppression of the JNK/AP-1 and β1-integrin signaling pathways. 
  • CYLD inhibits tumorigenesis and metastasis by blocking JNK/AP1 signaling at multiple levels. 
  • CaN19 expression in benign and malignant hyperplasias of the skin and oral mucosa: evidence for a role in regenerative differentiation. 
  • Can binimetinib, encorafenib and masitinib be more efficacious than currently available mutation-based targeted therapies for melanoma treatment? 
  • Can surgeons improve survival in stage IV melanoma? 
  • Cancer and pregnancy: the clinician's perspective. 
  • Cancer incidence among patients of the U.S. Veterans Affairs Health Care System. 
  • Caspase 3 promotes surviving melanoma tumor cell growth after cytotoxic therapy. 
  • Caspase-3 promotes genetic instability and carcinogenesis. 
  • Cdk2 deficiency decreases ras/CDK4-dependent malignant progression, but not myc-induced tumorigenesis. 
  • Cell adhesion protein expression in melanocytic matricoma. 
  • Cellular Blue Nevomelanocytic Lesions: Analysis of Clinical, Histological, and Outcome Data in 37 Cases. 
  • Central nervous system involvement by cutaneous T cell lymphoma. 
  • Central nervous system metastases in malignant melanoma. 
  • Cerebral cavernous malformations associated with cutaneous angiokeratomas and hemangiomas. 
  • Changes in oligosaccharide chains of autoantibodies to GRP78 expressed during progression of malignant melanoma stimulate melanoma cell growth and survival. 
  • Characteristics Associated with Pathologic Nodal Burden in Patients Presenting with Clinical Melanoma Nodal Metastasis. 
  • Characterization of Sentinel Lymph Node Immune Signatures and Implications for Risk Stratification for Adjuvant Therapy in Melanoma. 
  • Chemical skin carcinogenesis is prevented in mice by the induced expression of a TGF-beta related transgene. 
  • Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma. 
  • Chemokine receptors and melanoma metastasis. 
  • Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials. 
  • Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial. 
  • Chemopreventive apigenin controls UVB-induced cutaneous proliferation and angiogenesis through HuR and thrombospondin-1. 
  • Chemotherapy of subcutaneous and intracranial human medulloblastoma xenografts in athymic nude mice. 
  • Childhood lymphomatoid papulosis Type D, a rare and challenging diagnosis. 
  • Chromatophoromas and chromatophore hyperplasia in Pacific rockfish (Sebastes spp.). 
  • Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole. 
  • Clinical Trials in Melanoma: Margins, Lymph Nodes, Targeted and Immunotherapy. 
  • Clinical and dermoscopic features of 88 scalp naevi in 39 children. 
  • Clinical characteristics and prognostic factors of 70 patients with Sézary syndrome: a single-institutional experience at Moffitt cancer center. 
  • Clinical correlates of NRAS and BRAF mutations in primary human melanoma. 
  • Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. 
  • Clinical relevance of molecular staging for melanoma: comparison of RT-PCR and immunohistochemistry staining in sentinel lymph nodes of patients with melanoma. 
  • Clinically significant incidental findings among teledermatology patients with history of skin cancer. 
  • Clinicopathologic factors relating to surgical margins for cutaneous melanoma. 
  • Clinicopathologic study of 85 cases of melanoma of the female genitalia. 
  • Clonal persistence and evolution during a decade of recurrent melanoma. 
  • Clustering of cutaneous T-cell lymphoma is associated with increased levels of the environmental toxins benzene and trichloroethylene in the state of Georgia. 
  • Combined hyperspectral and spectral domain optical coherence tomography microscope for noninvasive hemodynamic imaging. 
  • Commentary on "A Step Toward Environmental Sustainability in Mohs Surgery". 
  • Common genetic polymorphisms contribute to the association between chronic lymphocytic leukaemia and non-melanoma skin cancer. 
  • Comparing in vivo pump-probe and multiphoton fluorescence microscopy of melanoma and pigmented lesions. 
  • Comparison between melanoma gene expression score and fluorescence in situ hybridization for the classification of melanocytic lesions. 
  • Comparison of diagnostic and management sensitivity to melanoma between dermatologists and MelaFind: a pilot study. 
  • Completeness of facial self-application of sunscreen in cosmetic surgery patients. 
  • Completion Lymph Node Dissection or Radiation Therapy for Sentinel Node Metastasis in Merkel Cell Carcinoma. 
  • Component-wise gradient boosting and false discovery control in survival analysis with high-dimensional covariates. 
  • Composite lymphoma of mycosis fungoides and cutaneous small B-cell lymphoma in a 73-year-old male patient. 
  • Computed Tomography-Based Limb Volume Measurements for Isolated Limb Infusion in Melanoma. 
  • Computed tomography in the detection of abdominal metastases from malignant melanoma. 
  • Concomitant Cutaneous Langerhans Cell Hystiocytosis and Leukemia Cutis. 
  • Congenital malignant melanoma. 
  • Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Delphi Consensus Statement. 
  • Contrast mechanisms in pump-probe microscopy of melanin. 
  • Correlates of skin-related quality of life (QoL) in those with multiple keratinocyte carcinomas (KCs): A cross-sectional study. 
  • Correlation of novel ALKATI with ALK immunohistochemistry and clinical outcomes in metastatic melanoma. 
  • Correlations of sun-protective behavior and intentional outdoor tanning among parent-teen dyads: A cross-sectional study. 
  • Correlations of unique clinical, immunotypic, and histologic findings in cutaneous gamma/delta T-cell lymphoma. 
  • Critical Assessment of Clinical Prognostic Tools in Melanoma. 
  • Current Trends in Management of Marjolin's Ulcer: A Systematic Review. 
  • Current management of melanoma. 
  • Current trends in regional therapy for melanoma: lessons learned from 225 regional chemotherapy treatments between 1995 and 2010 at a single institution. 
  • Curricular factors associated with medical students' practice of the skin cancer examination: an educational enhancement initiative by the integrated skin exam consortium. 
  • Cutaneous Angiosarcoma of the Eyelid Mimicking Morbihan Disease. 
  • Cutaneous Lymphoma. 
  • Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. 
  • Cutaneous Metastasis of Alveolar Rhabdomyosarcoma in a Child. 
  • Cutaneous Metastasis of a Mucoepidermoid Carcinoma of the Pancreas: First Reported Case. 
  • Cutaneous T cell lymphoma. Lymphocyte phenotype analysis after anti-thymocyte globulin therapy. 
  • Cutaneous T-cell lymphoma presenting as a rapidly enlarging ocular adnexal tumor. 
  • Cutaneous inflammatory myofibroblastic tumor with CARS-ALK fusion: Case report and literature review. 
  • Cutaneous involvement by T-cell prolymphocytic leukemia presenting as livedoid vasculopathy. 
  • Cutaneous lymphatic drainage in patients with grossly involved nodal basins. 
  • Cutaneous malignancies of the upper extremity. 
  • Cutaneous melanoma of the head and neck. A review of 399 cases. 
  • Cutaneous metastasis of SMARCA4-deficient thoracic sarcoma: A diagnostic dilemma with therapeutic implications. 
  • Cutaneous metastatic cholangiocarcinoma: a report of three cases and review of the literature. 
  • Cutaneous squamous cell carcinoma and human papillomavirus: is there an association? 
  • Cutaneous squamous cell carcinoma in a child. 
  • Cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. 
  • Cutaneous squamous cell carcinoma with zosteriform metastasis in a transplant recipient. 
  • Cutaneous tumor in a child. Cutaneous T-cell lymphoma (CTCL). 
  • Cutaneous wound healing through paradoxical MAPK activation by BRAF inhibitors 
  • Cutaneous γδ T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas. 
  • Cytokine therapy of cutaneous T-cell lymphoma: interferons, interleukin-12, and interleukin-2. 
  • Cytokinetic and molecular pharmacology studies of arabinosylcytosine in metastatic melanoma. 
  • Cytomorphology of primary small-cell (Merkel-cell) carcinoma of the skin in fine needle aspirates. 
  • DEK expression in Merkel cell carcinoma and small cell carcinoma. 
  • DEK expression in melanocytic lesions. 
  • DNA damage in peripheral blood mononuclear cells correlates with response to biochemotherapy in melanoma. 
  • DNA ploidy of malignant melanoma determined by image cytometry of fresh frozen and paraffin-embedded tissue. 
  • DNA repair and aging in basal cell carcinoma: a molecular epidemiology study. 
  • DNA repair and epidemiology of basal cell carcinoma. 
  • DNA repair and susceptibility to basal cell carcinoma: a case-control study. 
  • DNA repair capacity for ultraviolet light-induced damage is reduced in peripheral lymphocytes from patients with basal cell carcinoma. 
  • DNA repair gene XRCC3 241Met variant is not associated with risk of cutaneous malignant melanoma. 
  • DNA repair related to multiple skin cancers and drug use. 
  • Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. 
  • Defining early mycosis fungoides. 
  • Defining regional infusion treatment strategies for extremity melanoma: comparative analysis of melphalan and temozolomide as regional chemotherapeutic agents. 
  • Delayed onset of neurosarcoidosis after concurrent ipilimumab/nivolumab therapy. 
  • Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. 
  • Dermatofibrosarcoma protuberans and the Bednar tumor: treatment in the pediatric population. 
  • Dermatopathology of the foreskin: an institutional experience of over 400 cases. 
  • Desmoplastic Melanoma of the Periorbital Region. 
  • Detection of differentially abundant cell subpopulations in scRNA-seq data. 
  • Determining the False-Negative Rate Using Fluorescence Image-Assisted Sentinel Lymph Node Biopsy in Cutaneous Melanoma. 
  • Development of a Pigmented Facial Lesion Scale Based on Darkness and Extent of Lesions in Older Veterans. 
  • Development of a core outcome set for basal cell carcinoma. 
  • Development of cerebral air emboli during mohs micrographic surgery. 
  • Development of patient decision aids for the treatment of lentigo maligna and low-risk basal cell carcinoma. 
  • Diagnosis of melanoma by imaging mass spectrometry: Development and validation of a melanoma prediction model. 
  • Diagnosis of metastatic malignant melanoma by fine needle aspiration biopsy: a clinical and pathologic correlation of 298 cases. 
  • Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. 
  • Diagnostic accuracy and precision in assessing dermatologic disease. Problem or promise? 
  • Diagnostic accuracy of teledermatology for nonmelanoma skin cancer: Can patients be referred directly for surgical management? 
  • Diagnostic accuracy of whole slide imaging for cutaneous, soft tissue, and melanoma sentinel lymph node biopsies with and without immunohistochemistry. 
  • Differential Response of Mycosis Fungoides Cells to Vorinostat. 
  • Differential expression of N-cadherin distinguishes a subset of metastasizing desmoplastic melanomas. 
  • Differential volatile signatures from skin, naevi and melanoma: a novel approach to detect a pathological process. 
  • Differentiation of human T lymphocytes: II. Phenotypic difference in skin and blood malignant T-cells in cutaneous T-cell lymphoma. 
  • Diffuse neonatal hemangiomatosis: imaging findings in two patients. 
  • Discordance in Diagnosis of Melanocytic Lesions and Its Impact on Clinical Management. 
  • Discussion. 
  • Distant cutaneous granulomas after bacille Calmette-Guérin immunotherapy for malignant melanoma: case for direct infection. 
  • Distribution of CD44 variant isoforms in human skin: differential expression in components of benign and malignant epithelia. 
  • Do Patients Fill Their Postoperative Opioid Prescription After Mohs Surgery? A Retrospective Study. 
  • Dual-wavelength pump-probe microscopy analysis of melanin composition. 
  • Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy. 
  • Duration of voriconazole exposure: an independent risk factor for skin cancer after lung transplantation. 
  • ELR+ CXC chemokines and oncogenic Ras-mediated tumorigenesis. 
  • ENTPD1 (CD39) Expression Inhibits UVR-Induced DNA Damage Repair through Purinergic Signaling and Is Associated with Metastasis in Human Cutaneous Squamous Cell Carcinoma. 
  • Early melanoma detection: nonuniform dermoscopic features and growth. 
  • Early-stage melanoma and hematopoietic stem cell transplantation outcomes. 
  • Effect of aging on DNA repair and skin carcinogenesis: a minireview of population-based studies. 
  • Effect of health care delivery models on melanoma thickness and stage in a university-based referral center: an observational pilot study. 
  • Effects of appearance-based admonitions against sun exposure on tanning intentions in young adults. 
  • Effects of neuroimmune axis modulation by aprepitant on antipruritic and global disease severity in patients with cutaneous T-cell lymphoma. 
  • Effects of total-body digital photography on cancer worry in patients with atypical mole syndrome. 
  • Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial. 
  • Efficacy and safety of denileukin diftitox retreatment in patients with relapsed cutaneous T-cell lymphoma. 
  • Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. 
  • Efficacy of repeat sentinel lymph node biopsy in patients who develop recurrent melanoma. 
  • Elevated Serum Leptin Levels are Associated With an Increased Risk of Sentinel Lymph Node Metastasis in Cutaneous Melanoma. 
  • Enhanced malignant tumorigenesis in Cdk4 transgenic mice. 
  • Enhancing the immunostimulatory function of dendritic cells by transfection with mRNA encoding OX40 ligand. 
  • Epidemiologic support for melanoma heterogeneity using the Surveillance, Epidemiology, and End Results Program. 
  • Epidemiologic support for melanoma heterogeneity using the surveillance, epidemiology, and end results program. 
  • Erbium:YAG laser pretreatment accelerates the response of Bowen's disease treated by topical 5-fluorouracil. 
  • Eruptive Hypertrophic Discoid Lupus Erythematosus Mimicking Squamous Cell Carcinoma: A Clinical and Histopathological Diagnostic Challenge. 
  • Erythropoietin receptor contributes to melanoma cell survival in vivo. 
  • Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies. 
  • Evaluation of new putative tumor markers for melanoma. 
  • Evaluation of the long-term tolerability and clinical benefit of vorinostat in patients with advanced cutaneous T-cell lymphoma. 
  • Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma. 
  • Evidence that Gsta4 modifies susceptibility to skin tumor development in mice and humans. 
  • Evidence-Based Clinical Practice Guideline: Reconstruction after Skin Cancer Resection. 
  • Evidence-Based Clinical Practice Guideline: Reconstruction after Skin Cancer Resection. 
  • Evidence-based clinical practice guideline: Reconstruction after skin cancer resection. 
  • Examining the Incidence and Presentation of Melanoma in the Cardiothoracic Transplant Population. 
  • Examining the role of wide excision margins in pediatric melanoma: A National Cancer Database analysis. 
  • Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. 
  • Experimental chemotherapy of human medulloblastoma with classical alkylators. 
  • Expertise in Head and Neck Cutaneous Reconstructive Surgery. 
  • Exploring the association between melanoma and glioma risks. 
  • Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. 
  • Expression of cadherin/catenin cell--cell adhesion molecules in a onychomatricoma. 
  • Expression of plasminogen activators in basal cell carcinoma. 
  • Extent of surgical intervention in primary soft-tissue aspergillosis. 
  • External ocular pigmentation. 
  • Externally applied high-dose-rate brachytherapy for deeply invasive cutaneous squamous cell carcinoma in an older patient. 
  • FRA1 promotes squamous cell carcinoma growth and metastasis through distinct AKT and c-Jun dependent mechanisms. 
  • Factors associated with time to surgery in melanoma: An analysis of the National Cancer Database. 
  • Factors predicting toxicity and response following isolated limb infusion for melanoma: An international multi-centre study. 
  • Familial aggregation of melanoma, basal cell carcinoma, and gastric adenocarcinoma. 
  • Familial segregation of hemangiomas and vascular malformations as an autosomal dominant trait. 
  • Fatal pneumocystis pneumonia, cryptococcosis, and Kaposi sarcoma in a homosexual man. 
  • Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma. 
  • Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome). 
  • Fine needle aspiration biopsy of metastatic melanoma. A morphologic analysis of 174 cases. 
  • Fine-needle aspiration cytology of adenoid (acantholytic) squamous-cell carcinoma. 
  • Five hundred patients with Merkel cell carcinoma evaluated at a single institution. 
  • Follicular mucinosis as a presenting sign of acute myeloblastic leukemia. 
  • FoxP3 and indoleamine 2,3-dioxygenase immunoreactivity in sentinel nodes from melanoma patients. 
  • Freckles, moles, and melanomas. 
  • Free flap reconstruction of the scalp and calvaria of major neurosurgical resections in cancer patients: lessons learned closing large, difficult wounds of the dura and skull. 
  • Functional Variants in Notch Pathway Genes NCOR2, NCSTN, and MAML2 Predict Survival of Patients with Cutaneous Melanoma. 
  • GATA3 and MYB Expression in Cutaneous Adnexal Neoplasms. 
  • Gaining ground on a cure through synergy: combining checkpoint inhibitors with cancer vaccines. 
  • Gender differences in young adults' beliefs about sunscreen use. 
  • Gene expression profiling in melanoma: past results and future potential. 
  • Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression. 
  • Generalized cutaneous metastases from breast adenocarcinoma. 
  • Generalized papular xanthomatosis in mycosis fungoides. 
  • Generation of primary tumor-specific cytotoxic T lymphocytes from autologous and human lymphocyte antigen class I-matched allogeneic peripheral blood lymphocytes by B7 gene-modified melanoma cells. 
  • Genetic Variants in WNT2B and BTRC Predict Melanoma Survival. 
  • Genetic analysis of a family with hereditary glomuvenous malformations. 
  • Genetic linkage studies of chromosome 17 RFLPs in von Recklinghausen neurofibromatosis (NF1). 
  • Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma. 
  • Genetic variants in ELOVL2 and HSD17B12 predict melanoma-specific survival. 
  • Genetic variants in PDSS1 and SLC16A6 of the ketone body metabolic pathway predict cutaneous melanoma-specific survival. 
  • Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival. 
  • Genetic variants in TKT and DERA in the nicotinamide adenine dinucleotide phosphate pathway predict melanoma survival. 
  • Genetic variants in fanconi anemia pathway genes BRCA2 and FANCA predict melanoma survival. 
  • Genetic variants in glutamine metabolic pathway genes predict cutaneous melanoma-specific survival. 
  • Genetic variants in the calcium signaling pathway genes are associated with cutaneous melanoma-specific survival. 
  • Genetic variants in the folate metabolic pathway genes predict cutaneous melanoma-specific survival. 
  • Genetic variants in the genes encoding rho GTPases and related regulators predict cutaneous melanoma-specific survival. 
  • Genetic variants in the integrin signaling pathway genes predict cutaneous melanoma survival. 
  • Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival. 
  • Genetic variants in the vitamin D pathway genes VDBP and RXRA modulate cutaneous melanoma disease-specific survival. 
  • Genetic variants of SDCCAG8 and MAGI2 in mitosis-related pathway genes are independent predictors of cutaneous melanoma-specific survival. 
  • Genetic variants of the ADPRT, XRCC1 and APE1 genes and risk of cutaneous melanoma. 
  • Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma. 
  • Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans. 
  • Genome-wide association study identifies nidogen 1 (NID1) as a susceptibility locus to cutaneous nevi and melanoma risk. 
  • Genome-wide association study identifies novel alleles associated with risk of cutaneous basal cell carcinoma and squamous cell carcinoma. 
  • Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. 
  • Genome-wide association study identifies three new melanoma susceptibility loci. 
  • Genomic Classification of Cutaneous Melanoma. 
  • Giant cell fibroblastoma: a variant of dermatofibrosarcoma protruberans treated with Mohs' micrographic surgery. 
  • Glomeruloid hemangiomas localized to the skin of the trunk with no clinical features of POEMS syndrome. 
  • Glutathione S-transferase GSTP1 and cyclin D1 genotypes: association with numbers of basal cell carcinomas in a patient subgroup at high-risk of multiple tumours. 
  • Guidelines for phototherapy of mycosis fungoides and Sézary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium. 
  • HIV infection in children. 
  • HPV-16-related DNA sequences in Kaposi's sarcoma. 
  • Hairy cell leukemia-associated familial lymphoproliferative disorder: immunologic abnormalities in unaffected family members. 
  • Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non-Hispanic whites in Texas: a case-control study. 
  • Hat, shade, long sleeves, or sunscreen? Rethinking US sun protection messages based on their relative effectiveness. 
  • Hazard-rate analysis and patterns of recurrence in early stage melanoma: moving towards a rationally designed surveillance strategy. 
  • Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma. 
  • Hedgehog inhibitors with and without adjunctive therapy in treatment of locally advanced basal cell carcinoma. 
  • Hibernoma: 18F FDG PET/CT imaging. 
  • Histology of early lesions of AIDS-associated Kaposi's sarcoma. 
  • Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma. 
  • Histopathologic characteristics, recurrence patterns, and survival of 129 patients with desmoplastic melanoma. 
  • Host pigment epithelium-derived factor (PEDF) prevents progression of liver metastasis in a mouse model of uveal melanoma. 
  • How high the SPF? 
  • Human T cells specifically activated against autologous malignant melanoma. 
  • Human melanoma cell migration along capillary-like structures in vitro: a new dynamic model for studying extravascular migratory metastasis. 
  • Hydroxychloroquine-induced hyperpigmentation: the staining pattern. 
  • IDH1(R132) mutation identified in one human melanoma metastasis, but not correlated with metastases to the brain. 
  • IRTA1 positivity helps identify a MALT-lymphoma-like subset of primary cutaneous marginal zone lymphomas, largely but not exclusively defined by IgM expression. 
  • Identification of a melanoma susceptibility locus and somatic mutation in TET2. 
  • Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV. 
  • Image of the month. 
  • Image-Guided Placement of Osseointegrated Implants for Challenging Auricular, Orbital, and Rhinectomy Defects. 
  • Immunity to commensal papillomaviruses protects against skin cancer. 
  • Immunohistochemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma. 
  • Immunohistochemical markers in fibrohistiocytic lesions: factor XIIIa, CD34, S-100 and p75. 
  • Immunohistochemistry as a reliable method for detection of BRAF-V600E mutation in melanoma: a systematic review and meta-analysis of current published literature. 
  • Immunohistochemistry in the diagnosis of cutaneous neoplasms. 
  • Immunophenotypic Shifts in Primary Cutaneous γδ T-Cell Lymphoma Suggest Antigenic Modulation: A Study of Sequential Biopsy Specimens. 
  • Immunotherapy With Programmed Cell Death 1 Inhibitors for 5 Patients With Conjunctival Melanoma. 
  • Immunotherapy for malignant melanoma with a tumor cell vaccine. 
  • Importance of sentinel lymph node biopsy in patients with thin melanoma. 
  • Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma. 
  • Improving interstitial transport of macromolecules through reduction in cell volume fraction in tumor tissues. 
  • In vitro determination of thymidine-3H labeling index in human solid tumors. 
  • In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis. 
  • In vivo label-free photoacoustic flow cytography and on-the-spot laser killing of single circulating melanoma cells. 
  • In-transit melanoma metastases: incidence, prognosis, and the role of lymphadenectomy. 
  • Incidence and management of Kaposi sarcoma in renal transplant recipients: the Greek experience. 
  • Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease. 
  • Increased skin carcinogenesis in caspase-activated DNase knockout mice. 
  • Indocyanine Green Fluorescence Imaging with Lymphoscintigraphy Improves the Accuracy of Sentinel Lymph Node Biopsy in Melanoma. 
  • Indocyanine Green Fluorescence Imaging with Lymphoscintigraphy for Sentinel Node Biopsy in Melanoma: Increasing the Sentinel Lymph Node-Positive Rate. 
  • Indocyanine green fluorescence imaging with lymphoscintigraphy for sentinel node biopsy in head and neck melanoma. 
  • Influence of single nucleotide polymorphisms in the MMP1 promoter region on cutaneous melanoma progression. 
  • Influence of trauma on the unusual distribution of metastases from carcinoma of the larynx. 
  • Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy. 
  • Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma. 
  • Inhibition of the growth of human melanoma metastases in nude mice by melanoma-specific murine monoclonal antibody. 
  • Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines. 
  • Initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models. 
  • Integrated pathway and epistasis analysis reveals interactive effect of genetic variants at TERF1 and AFAP1L2 loci on melanoma risk. 
  • Interferon Alfa-2b or not 2b? Significant differences exist in the decision-making process between melanoma patients who accept or decline high-dose adjuvant interferon Alfa-2b treatment. 
  • Interferon alfa-2a in the treatment of cutaneous T cell lymphoma. 
  • Interferon in the treatment of cutaneous T-cell lymphoma. 
  • Interferon in the treatment of cutaneous T-cell lymphoma. 
  • International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients. 
  • Intralesional BCG, intravenous immune lymphocytes, and immunization with neuraminidase-treated tumor cells to manage melanoma; A clinical assessment. 
  • Intraoperative angiography using laser-assisted indocyanine green imaging to map perfusion of forehead flaps. 
  • Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. 
  • Intratumoral and peritumoral lymphovascular invasion detected by D2-40 immunohistochemistry correlates with metastasis in primary cutaneous Merkel cell carcinoma. 
  • Intratumoral consumption of indium-111 labeled platelets in a patient with hemangiomatosis and intravascular coagulation (Kasabach-Merritt syndrome). 
  • Inverse Relationship between Vitiligo-Related Genes and Skin Cancer Risk. 
  • Investigative studies in the diagnosis and treatment of melanoma. 
  • Investment in new technology research can save future health care dollars. 
  • In vitro and in vivo evaluation of resveratrol and 3,5-dihydroxy-4'-acetoxy-trans-stilbene in the treatment of human prostate carcinoma and melanoma. 
  • Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion. 
  • Isolated metastatic melanoma to the colon mimicking colon cancer. 
  • Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma. 
  • Juvenile malignant melanoma. 
  • Kaposi sarcoma in a patient with postpolio syndrome. 
  • Kaposi's sarcoma in homosexual men-a report of eight cases. 
  • Keratinocyte growth regulation TRP-ed up over downregulated TRPV4? 
  • Ki-67, p53, and p16 expression, and G691S RET polymorphism in desmoplastic melanoma (DM): A clinicopathologic analysis of predictors of outcome. 
  • Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues. 
  • Large Nonmelanoma Skin Tumors in Older Adults with Multiple Comorbidities: A Case-Control Study. 
  • Laser-induced fluorescence spectroscopy for in vivo diagnosis of non-melanoma skin cancers. 
  • Late growth of infantile hemangiomas in children >3 years of age: A retrospective study. 
  • Late onset of isolated central nervous system metastasis of liposarcoma--a case report. 
  • Late recurrence of malignant melanoma. Analysis of 168 patients. 
  • Lesion identification and malignancy prediction from clinical dermatological images. 
  • Lethal "thin" malignant melanoma. Identifying patients at risk. 
  • Leukonychia related to vorinostat. 
  • Lifetime Occurrence of Brain Metastases Arising from Lung, Breast, and Skin Cancers in the Elderly: A SEER-Medicare Study. 
  • Limb preservation with isolated limb infusion for locally advanced nonmelanoma cutaneous and soft-tissue malignant neoplasms. 
  • Limited utility of repeated vital sign monitoring during initiation of oral propranolol for complicated infantile hemangioma. 
  • Liver resection for metastatic melanoma with postoperative tumor-infiltrating lymphocyte therapy. 
  • Local control and distant metastases in primary canine malignant melanomas treated with hyperthermia and/or radiotherapy. 
  • Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis. 
  • Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases. 
  • Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis. 
  • Lower extremity lymphedema caused by acquired immune deficiency syndrome-related Kaposi's sarcoma: case report and review of the literature. 
  • Lymphatic mapping and sentinel lymphadenectomy in primary cutaneous melanoma. 
  • Lymphatic mapping and sentinel node analysis: current concepts and applications. 
  • Lymphoscintigraphy for malignant melanoma. Surgical considerations. 
  • Lymphoscintigraphy in malignant melanoma: 99mTc antimony sulfur colloid. 
  • Lysosomes and the skin. 
  • Macrophage migratory dysfunction in cancer. A mechanism for subversion of surveillance. 
  • Malignancy Risk and Recurrence with Psoriasis and its Treatments: A Concise Update. 
  • Malignancy after solid organ transplantation: an overview. 
  • Malignant Melanoma: Diagnostic and Management Update. 
  • Malignant melanoma and pregnancy. 
  • Malignant melanoma and pregnancy. 
  • Malignant melanoma arising during pregnancy. A study of 100 patients. 
  • Malignant melanoma in black American and white American populations. A comparative review. 
  • Malignant melanoma in children. 
  • Malignant melanoma in the American black. 
  • Malignant melanoma in the elderly. 
  • Management of a cutaneous squamous cell carcinoma overlying an AV fistula. 
  • Management of primary squamous cell carcinoma at the mucocutaneous junction of an ileal conduit. 
  • Management of recurrent melanoma of the extremity. 
  • Management strategies of academic pigmented lesion clinic directors in the United States. 
  • Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides. 
  • Mantle Cell Lymphoma Involving Skin: A Clinicopathologic Study of 37 Cases. 
  • Marked variability of melphalan plasma drug levels during regional hyperthermic isolated limb perfusion. 
  • Measuring the severity of topical 5-fluorouracil toxicity. 
  • Melanocytic nevi with nonsurgical trauma: a histopathologic study. 
  • Melanocytic tumors with intraepidermal melanophages: a report of five cases with review of 231 archived cutaneous melanocytic tumors. 
  • Melanoma Expression Genes Identified through Genome-Wide Association Study of Breslow Tumor Thickness. 
  • Melanoma arising in a skin graft. 
  • Melanoma of the foot. 
  • Melanoma of the gallbladder: a review of cases seen at Duke University Medical Center. 
  • Melanoma outcomes for Medicare patients: association of stage and survival with detection by a dermatologist vs a nondermatologist. 
  • Melanoma patients evaluated by four different positron emission tomography reconstruction techniques. 
  • Melanoma proliferation and chemoresistance controlled by the DEK oncogene. 
  • Melanoma reporting to central cancer registries by US dermatologists: an analysis of the persistent knowledge and practice gap. 
  • Melanoma trials that defined surgical management: Overview of trials that established NCCN margin guidelines. 
  • Melanoma underreporting among US dermatopathologists: A pilot study. 
  • Melanoma, a tumor based on a mutant stem cell? 
  • Melanoma-associated retinopathy: a presenting sign of metastatic disease. 
  • Melanoma-derived conditioned media efficiently induce the differentiation of monocytes to macrophages that display a highly invasive gene signature. 
  • Melanoma. 
  • Melanomas of Unknown Primary May Have a Distinct Molecular Classification to Explain Differences in Patient Outcomes. 
  • Melastatin expression and prognosis in cutaneous malignant melanoma. 
  • Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. 
  • Merkel cell carcinoma with partial B-cell blastic immunophenotype: a potential mimic of cutaneous richter transformation in a patient with chronic lymphocytic lymphoma. 
  • Merkel cell carcinoma. 
  • Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data. 
  • Merkel cell carcinoma: prognosis and treatment of patients from a single institution. 
  • Merkel cell polyomavirus small tumour antigen activates the p38 MAPK pathway to enhance cellular motility. 
  • Merkel cell tumor. 
  • Meta-analysis of number needed to treat for diagnosis of melanoma by clinical setting. 
  • Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials. 
  • Metastatic Melanoma Patient-Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition. 
  • Metastatic Merkel cell carcinoma (MCC) of pancreas and breast: a unique case. 
  • Metastatic malignant melanoma in an endometrial polyp. 
  • Metastatic malignant melanoma with an unknown primary. 
  • Metastatic melanoma in the thorax: report of 130 patients. 
  • Metastatic melanoma to the spine. Demographics, risk factors, and prognosis in 114 patients. 
  • Metastatic squamous cell carcinoma of the nasal tip: a case report. 
  • Metastatic squamous cell carcinoma with pseudoangiosarcomatous features and aberrant expression of vascular markers. 
  • Metastatic vs primary malignant neoplasms affecting the umbilicus: clinicopathologic features of 77 tumors. 
  • Methyltransferase inhibitors restore SATB1 protective activity against cutaneous T cell lymphoma in mice. 
  • Mibefradil, a novel therapy for glioblastoma multiforme: cell cycle synchronization and interlaced therapy in a murine model. 
  • Minimally invasive intra-arterial regional therapy for metastatic melanoma: isolated limb infusion and percutaneous hepatic perfusion. 
  • Mining database for the expression and gene regulation network of JAK2 in skin cutaneous melanoma. 
  • Modeling tumor onset and multiplicity using transition models with latent variables. 
  • Modern approaches to photoprotection. 
  • Modulation of chemotherapy resistance in regional therapy: a novel therapeutic approach to advanced extremity melanoma using intra-arterial temozolomide in combination with systemic O6-benzylguanine. 
  • Modulation of specific active immunization against murine melanoma using recombinant cytokines. 
  • Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis. 
  • Mohs versus traditional surgical excision for facial and auricular nonmelanoma skin cancer: an analysis of cost-effectiveness. 
  • Molecular characterization of inflammatory genes in sentinel and nonsentinel nodes in melanoma. 
  • Molecular classification of cutaneous malignant melanoma by gene expression profiling. 
  • Molecular dissection of the miR-17-92 cluster's critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation. 
  • Molecular interactions of B-CAM (basal-cell adhesion molecule) and laminin in epithelial skin cancer. 
  • Molecular staging of malignant melanoma: correlation with clinical outcome. 
  • Monoclonal antibody localization in subcutaneous and intracranial human glioma xenografts: paired-label and imaging analysis. 
  • Morphea following treatment with pembrolizumab for melanoma with metastatic lymph nodes: case report and review of literature. 
  • Morphomics predicts response to ipilimumab in patients with stage IV melanoma. 
  • Mucosal melanoma. 
  • Multiple Clustered Dermatofibromas Associated With Pulmonary Arterial Hypertension. 
  • Multiple benign juvenile melanoma. 
  • Multiple blue papules. Hereditary glomangiomas. 
  • Multiple primary melanoma: incidence and risk factors in 283 patients. 
  • Multiply recurrent trichilemmal carcinoma with perineural invasion and cytokeratin 17 positivity. 
  • Multivariate procedures to describe clinical staging of melanoma. 
  • Mycosis fungoides. 
  • Myocarditis associated with immune checkpoint inhibitor therapy: a case report of three patients. 
  • NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020. 
  • NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021. 
  • NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022. 
  • Nail discoloration in pediatric skin of color patients. 
  • National Trends in Management of Pathologic Stage III Melanoma. 
  • Natural and orthogonal model for estimating gene-gene interactions applied to cutaneous melanoma. 
  • Neoadjuvant use of ipilimumab in locally advanced melanoma. 
  • Neuro-oculo-cutaneous cavernous hemangiomas: a CCM1 mutation-associated phakomatosis. 
  • Neurofibroma with clear cell change. 
  • Never underestimate a dermal lesion: reflections on a rare tumor. 
  • New Developments in the Management of Cutaneous Squamous Cell Carcinoma. 
  • New NCCN Guidelines for Uveal Melanoma and Treatment of Recurrent or Progressive Distant Metastatic Melanoma. 
  • Nitric oxide and neopterin levels and clinical response in stage III melanoma patients receiving concurrent biochemotherapy. 
  • Nodal Recurrence as Primary Driver of Early Relapse in Patients with SLN-Positive Melanoma: What Does It Mean for Providers and Patients? 
  • Non-Operative Options for Loco-regional Melanoma. 
  • Non-specific and specific immunotherapy in patients with melanoma. 
  • Noninvasive optical spectroscopy for identification of non-melanoma skin cancer: Pilot study. 
  • Nonlinear microscopy of eumelanin and pheomelanin with subcellular resolution. 
  • Nonmelanoma skin cancer in inflammatory bowel disease: a review. 
  • Nonsynonymous somatic mitochondrial mutations occur in the majority of cutaneous melanomas. 
  • Nucleotide excision repair as a marker for susceptibility to tobacco-related cancers: a review of molecular epidemiological studies. 
  • OX40+ Regulatory T Cells in Cutaneous Squamous Cell Carcinoma Suppress Effector T-Cell Responses and Associate with Metastatic Potential. 
  • Occupational aspects of scrotal cancer and epithelioma. 
  • Occurrence of subclinical tumor in excised facial subunits. 
  • On angiomas of retina, brain, and skin. 
  • On the interplay of telomeres, nevi and the risk of melanoma. 
  • Oncologic Outcomes After Isolated Limb Infusion for Advanced Melanoma: An International Comparison of the Procedure and Outcomes Between the United States and Australia. 
  • Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II). 
  • Oncolytic viruses in melanoma. 
  • Optimizing melphalan pharmacokinetics in regional melanoma therapy: does correcting for ideal body weight alter regional response or toxicity? 
  • Optimizing regional infusion treatment strategies for melanoma of the extremities. 
  • Optimizing regional therapy for melanoma. 
  • Outcomes and predictors of survival in cutaneous melanoma of the eyelid: An analysis of the National Cancer Database. 
  • Outcomes of Single Node Excision Compared with Lymph Node Dissection for Patients with Clinical Stage III N1b Cutaneous Melanoma. 
  • Outcomes of adjunctive therapies post hedgehog inhibitors in the management of locally advanced basal cell carcinoma: A systematic review and pooled analysis. 
  • Outcomes of patients with a pretransplant history of early-stage melanoma. 
  • Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection. 
  • Overview of melanoma vaccines and promising approaches. 
  • PGC-1 coactivators regulate MITF and the tanning response. 
  • PHGDH amplification and altered glucose metabolism in human melanoma. 
  • Palliative surgery for head and neck cancer with extensive skin involvement. 
  • Paraganglioma-like dermal melanocytic tumor: a unique entity distinct from cellular blue nevus, clear cell sarcoma, and cutaneous melanoma. 
  • Paraneoplastic retinopathy with multiple detachments of the neurosensory retina and autoantibodies against interphotoreceptor retinoid binding protein (IRBP) in cutaneous melanoma. 
  • Patient education: recommendations regarding sunscreens, drugs, and diet. 
  • Patterns of GRP78 and MTJ1 expression in primary cutaneous malignant melanoma. 
  • Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma. 
  • Patterns of recurrence and prognosis in pathologic stage I and II Merkel cell carcinoma: A multicenter, retrospective cohort analysis. 
  • Pediatric cutaneous angiosarcomas: a clinicopathologic study of 10 cases. 
  • Pediatric melanoma. 
  • Pediatric melanoma: a single-institution experience of 150 patients. 
  • Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. 
  • Pediatric surgical pearls: minimizing complications. 
  • Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial. 
  • Pentostatin (2'-deoxycoformycin) in the treatment of cutaneous T-cell lymphoma. 
  • Pericytic-like angiotropism of glioma and melanoma cells. 
  • Perinatal Considerations in Women With Previous Diagnosis of Cancer. 
  • Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma. 
  • Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and Leukemia Group B 509901. 
  • Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma. 
  • Phase I/II open-label study of the biologic effects of the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with metastatic malignant melanoma. 
  • Phase II study of predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer with lapatinib monotherapy. 
  • Phase II study of temozolomide and thalidomide in patients with metastatic melanoma in the brain: high rate of thromboembolic events (CALGB 500102). 
  • Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104). 
  • Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma. 
  • Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells. 
  • Photoionization thresholds of melanins obtained from free electron laser-photoelectron emission microscopy, femtosecond transient absorption spectroscopy and electron paramagnetic resonance measurements of oxygen photoconsumption. 
  • Pigmented Corneal Mass in a 59-Year-Old Man With Cutaneous Melanoma. 
  • Pigmented Lesions of the Nervous System and the Neural Crest: Lessons From Embryology. 
  • Plasma cell problems: Case 1. Disseminated cutaneous plasmacytomas treated with total skin electron radiotherapy. 
  • Plasma cytokine analysis in patients with advanced extremity melanoma undergoing isolated limb infusion. 
  • Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis. 
  • Polymorphisms of TP53 Arg72Pro, but not p73 G4C14>A4TA4 and p21 Ser31Arg, contribute to risk of cutaneous melanoma. 
  • Polymorphisms of nucleotide excision repair genes predict melanoma survival. 
  • Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma. 
  • Polymorphisms of the neuronal and inducible nitric oxide synthase genes and the risk of cutaneous melanoma: a case-control study. 
  • Positron emission tomography scanning in malignant melanoma. 
  • Posterior Uveitis Associated with Cemiplimab. 
  • Postradiation sarcoma: case report and review of the potential complications of therapeutic ionizing radiation. 
  • Pre-treated anti-PD-1 refractory Merkel cell carcinoma successfully treated with the combination of PD-1/PD-L1 axis inhibitors and TVEC: a report of two cases. 
  • Predictable tissue shrinkage during frozen section histopathologic processing for Mohs micrographic surgery. 
  • Predicting disease progression after regional therapy for in-transit melanoma. 
  • Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma. 
  • Predictors of False Negative Sentinel Lymph Node Biopsy in Clinically Localized Merkel Cell Carcinoma. 
  • Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial. 
  • Predictors of complete responses with denileukin diftitox in cutaneous T-cell lymphoma. 
  • Pregnancy and changes in melanocytic nevi. 
  • Prevalence and characteristics of indoor tanning use among men and women in the United States. 
  • Prevention and early detection of melanoma: a surgeon's perspective. 
  • Primary Cutaneous T-Cell Lymphomas Showing Gamma-Delta (γδ) Phenotype and Predominantly Epidermotropic Pattern are Clinicopathologically Distinct From Classic Primary Cutaneous γδ T-Cell Lymphomas. 
  • Primary care clinicians' performance for detecting actinic keratoses and skin cancer. 
  • Primary chondroid melanoma. 
  • Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas. 
  • Primary cutaneous giant cell plasmacytoma in an organ transplant recipient: a rare presentation of a posttransplant lymphoproliferative disorder. 
  • Primary cutaneous lymphoma of the head and neck. 
  • Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC. 
  • Primary cutaneous, composite, Epstein-Barr virus-associated, diffuse large B-cell lymphoma and peripheral T-cell lymphoma. 
  • Primary mucinous carcinoma of the eyelid: a clinicopathologic and immunohistochemical study of 4 cases and an update on recurrence rates. 
  • Probing skin pigmentation changes with transient absorption imaging of eumelanin and pheomelanin. 
  • Prognosis for recurrent stage I malignant melanoma. 
  • Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. 
  • Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade. 
  • Prognostic or Therapeutic-The Role of Sentinel Lymph Node Biopsy in Contemporary Practice. 
  • Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors. 
  • Proliferative nodules arising within congenital melanocytic nevi: a histologic, immunohistochemical, and molecular analyses of 43 cases. 
  • Promoter polymorphisms in matrix metallopeptidase 1 and risk of cutaneous melanoma. 
  • Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma. 
  • Protein farnesyltransferase in embryogenesis, adult homeostasis, and tumor development. 
  • Pruritus in patients with solid tumors: an overlooked supportive care need. 
  • Psychosocial factors in sunbathing and sunscreen use. 
  • Pump-probe imaging differentiates melanoma from melanocytic nevi. 
  • Punch biopsy vs. shave biopsy: a comparison of margin status of clinically atypical pigmented lesions. 
  • Pyogenic variant of primary cutaneous anaplastic large-cell lymphoma: a lymphoproliferative disorder with a predilection for the immunocompromized and the young. 
  • QT interval prolongation and torsades de pointes in a patient undergoing treatment with vorinostat: a case report and review of the literature. 
  • Quality-of-life improvements in cutaneous T-cell lymphoma patients treated with denileukin diftitox (ONTAK). 
  • Quantifying melanin spatial distribution using pump-probe microscopy and a 2-D morphological autocorrelation transformation for melanoma diagnosis. 
  • Race as a predictor of patient preferences for biopsy result communication. 
  • Radiation Therapy for Cutaneous T-Cell Lymphomas. 
  • Radical radiotherapy for T4 carcinoma of the skin of the head and neck: a multivariate analysis. 
  • Radionuclide lymphoscintigraphy with technetium 99m antimony sulfide colloid to identify lymphatic drainage of cutaneous melanoma at ambiguous sites in the head and neck and trunk. 
  • Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020. 
  • Randomized trial of hyperthermia and radiation for superficial tumors. 
  • Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma. 
  • Rapid growth of cutaneous metastases after surgical resection of thrombospondin-secreting small blue round cell tumor of childhood. 
  • Reconstruction of a full-thickness alar wound with a single operative procedure. 
  • Reconstruction of nasal defects 1.5 cm or smaller. 
  • Reconstruction of scalp wounds with exposed calvarium using a local flap and a split-thickness skin graft: case series of 20 patients. 
  • Reconstructive utility of the bilobed flap: lessons from flap successes and failures. 
  • Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma. 
  • Recurrent malignant melanoma: the identification of prognostic factors to predict survival. 
  • Recurrent papules on the left upper extremity of a 50-year-old man. 
  • Redox properties of cytochrome oxidase and vascular reactivity of astrocytomas and neuroblastomas in vivo. 
  • Refractory myasthenia gravis exacerbation triggered By pembrolizumab. 
  • Regional control after precision lymph node dissection for clinically evident melanoma metastasis. 
  • Regional squamous cell carcinomas following systemic sorafenib therapy and isolated limb infusion for regionally advanced metastatic melanoma of the limb. 
  • Reliable methods to evaluate the burden of actinic keratoses. 
  • Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression. 
  • Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. 
  • Reply to: Beta human papillomaviruses and skin cancer. 
  • Response of malignant scalp dermatofibrosarcoma to presurgical targeted growth factor inhibition. 
  • Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer. 
  • Review of the treatment of mycosis fungoides and sézary syndrome: a stage-based approach. 
  • Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). 
  • Rhabdomyomatous mesenchymal hamartoma presenting as a sacral skin tag in two neonates with spinal dysraphism. 
  • Risk of Skin Cancers in Older Persons Living With HIV: A Systematic Review. 
  • Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins. 
  • Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. 
  • Rituximab monotherapy to treat intravascular large B-cell lymphoma manifesting as pruritic calf patch in an elderly female. 
  • Role of Immune Response, Inflammation, and Tumor Immune Response-Related Cytokines/Chemokines in Melanoma Progression. 
  • Role of imaging in low-grade cutaneous B-cell lymphoma presenting in the skin. 
  • Rural health disparities in melanoma staging and prognostic outcomes in Iowa. 
  • Safety and Efficacy of Mohs Micrographic Surgery in Children and Adolescents: A Systematic Review. 
  • Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection in Patients With Melanoma (SAFE-MILND): Report of a Prospective Multi-institutional Trial. 
  • Sarcopenia as a prognostic factor among patients with stage III melanoma. 
  • Screening and surveillance for second malignant neoplasms in adult survivors of childhood cancer: a report from the childhood cancer survivor study. 
  • Second malignancies in cutaneous T cell lymphoma. 
  • Segmenting skin lesions with partial-differential-equations-based image processing algorithms. 
  • Segregation analysis in cutaneous malignant melanoma/dysplastic nevus syndrome families. 
  • Selection and validation of endogenous reference genes using a high throughput approach. 
  • Selection of patients with melanoma brain metastases for aggressive treatment. 
  • Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesis. 
  • Selective inhibition of JNK with a peptide inhibitor attenuates pain hypersensitivity and tumor growth in a mouse skin cancer pain model. 
  • Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma. 
  • Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study. 
  • Sentinel lymph node biopsy following a rotational flap. 
  • Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. 
  • Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. 
  • Sentinel lymph node biopsy in melanoma of the head and neck. 
  • Sentinel lymph node biopsy is a prognostic measure in pediatric melanoma. 
  • Sentinel lymph node detection using laser-assisted indocyanine green dye lymphangiography in patients with melanoma. 
  • Sentinel node biopsy for head and neck melanoma: a systematic review. 
  • Severe cutaneous and neurologic toxicity in melanoma patients during vemurafenib administration following anti-PD-1 therapy. 
  • Sex related survival differences in instances of melanoma. 
  • Sister (Mary?) Joseph's node. 
  • Skeletal metastases of melanoma. 
  • Skin Cancer Risk Factors and Preventative Behaviors among United States Military Veterans Deployed to Iraq and Afghanistan. 
  • Skin Cancer Risk Factors and Screening Among Asian American Individuals. 
  • Skin cancer in the military: A systematic review of melanoma and nonmelanoma skin cancer incidence, prevention, and screening among active duty and veteran personnel. 
  • Skin cancer prevalence and risk among foreign-born people living in the United States: A pooled cross-sectional analysis. 
  • Skin cancer risk factors and screening among sexual minority and heterosexual women. 
  • Skin cancer surveillance practices and attitudes among hairdressers: A cross-sectional study in Atlanta, Georgia. 
  • Skin manifestations in individuals of African or Asian descent. 
  • Skin melanoma. Cured fraction and survival time as functions of thickness, site, histologic type, age, and sex. 
  • Skin metastases confined to a field of previous irradiation. Report of two cases and review of the literature. 
  • Skp2 deficiency inhibits chemical skin tumorigenesis independent of p27(Kip1) accumulation. 
  • Snail maintains the stem/progenitor state of skin epithelial cells and carcinomas through the autocrine effect of matricellular protein Mindin. 
  • Solid tumor second primary neoplasms: who is at risk, what can we do? 
  • Solitary pulmonary metastases in high-risk melanoma patients: a prospective comparison of conventional and computed tomography. 
  • Spatial biology analysis reveals B cell follicles in secondary lymphoid structures may regulate anti-tumor responses at initial melanoma diagnosis. 
  • Specific active immunotherapy for melanoma. 
  • Spinal capillary hemangioma in infants: report of two cases and review of the literature. 
  • Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis. 
  • Spitz nevi in black children. 
  • Sporadic cutaneous angiosarcomas: a proposal for risk stratification based on 69 cases. 
  • Squamous cell carcinoma of the legs in African Americans. 
  • Squamous cell skin cancer in the north-west of England, 1967--69, and its relation to occupation. 
  • Stage II malignant melanoma: presentation of a prognostic model and an assessment of specific active immunotherapy in 1,273 patients. 
  • Stat3 binds to mtDNA and regulates mitochondrial gene expression in keratinocytes. 
  • Statistical analysis of skin tumor data from Tg.AC mouse bioassays. 
  • Statistical analysis of the concordance of immunohistochemical stains with the final diagnosis in spitzoid neoplasms. 
  • Studying health histories of cancer: a new model connecting cancer incidence and survival. 
  • Subungual leiomyoma in the left thumb of a 16-year-old female. 
  • Sunscreen use in NCAA collegiate athletes: identifying targets for intervention and barriers to use. 
  • Supply-and-demand discrepancy in academic pigmented lesion clinics: a case for a new health care delivery model. 
  • Suramin keratosis: a unique skin eruption in a patient receiving suramin for metastatic prostate cancer. 
  • Surgical management of Merkel cell carcinoma. 
  • Surgical management of aberrant sentinel lymph node drainage in cutaneous melanoma. 
  • Surgical management of cutaneous melanoma: current practice and impact on prognosis. 
  • Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients. 
  • Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection. 
  • Surgical margins around primary cutaneous melanomas. 
  • Surgical therapy of cutaneous melanoma. 
  • Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis. 
  • Surveillance strategies in the follow-up of melanoma patients: too much or not enough? 
  • Surveillance, Epidemiology, and End Results (SEER) database analysis of microcystic adnexal carcinoma (sclerosing sweat duct carcinoma) of the skin. 
  • Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program. 
  • Survival is not the only valuable end point in melanoma screening. 
  • Survival superiority of females with melanoma. A multivariate analysis of 6383 patients exploring the significance of gender in prognostic outcome. 
  • Survival, disease progression and prognostic factors in elderly patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of 174 patients. 
  • Switching the Smoothened Inhibitor May Have Benefit in Advanced Basal Cell Carcinoma. 
  • Synchronous primary perianal Paget's disease and rectal adenocarcinoma: report of a hitherto undescribed phenomenon. 
  • Systemic Therapies for Melanoma Brain Metastases: A Primer for Radiologists. 
  • Sézary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC). 
  • T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases. 
  • T-cell receptor-δ expression and γδ+ T-cell infiltrates in primary cutaneous γδ T-cell lymphoma and other cutaneous T-cell lymphoproliferative disorders. 
  • TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). 
  • Targeting N-cadherin increases vascular permeability and differentially activates AKT in melanoma. 
  • Targeting the IL-2 inducible kinase in melanoma; a phase 2 study of ibrutinib in systemic treatment-refractory distant metastatic cutaneous melanoma: preclinical rationale, biology, and clinical activity (NCI9922). 
  • Technology-enabled activation of skin cancer screening for hematopoietic cell transplantation survivors and their primary care providers (TEACH). 
  • Teenage acne and cancer risk in US women: A prospective cohort study. 
  • Temozolomide is a novel regional infusion agent for the treatment of advanced extremity melanoma. 
  • That's Not Molluscum! A literature review of 109 cases of subepidermal calcified nodules. 
  • The Anterolateral Thigh Flap as the Flap of Choice for Scalp Reconstruction. 
  • The Association of MUC16 Mutation with Tumor Mutation Burden and Its Prognostic Implications in Cutaneous Melanoma. 
  • The Clinical Spectrum of Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoproliferative Disorder: An Updated Systematic Literature Review and Case Series. 
  • The Devil's in the Details: Discrepancy Between Biopsy Thickness and Final Pathology in Acral Melanoma. 
  • The Emerging Role of Surgery for Patients With Advanced Melanoma Treated With Immunotherapy. 
  • The Genomic Landscape of Actinic Keratosis. 
  • The Landmark Series: Regional Therapy of Recurrent Cutaneous Melanoma. 
  • The Skin Cancer Objective Structured Clinical Examination (SCOSCE): A multi-institutional collaboration to develop and validate a clinical skills assessment for melanoma. 
  • The State of Melanoma: Emergent Challenges and Opportunities. 
  • The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling. 
  • The United States Cutaneous Lymphoma Consortium (USCLC). 
  • The Use and Technique of Sentinel Node Biopsy for Skin Cancer. 
  • The c-Jun NH2-terminal kinase 2 plays a dominant role in human epidermal neoplasia. 
  • The changing landscape of dermatology practice: melanoma and pump-probe laser microscopy. 
  • The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus-associated disease. A study of 50 patients. 
  • The effect of radiation therapy on microcystic adnexal carcinoma: a case report. 
  • The efficacy of anti-PD-1 agents in acral and mucosal melanoma. 
  • The efficacy of full-lung tomography in the detection of early metastatic disease from melanoma. 
  • The examination of several common misconceptions in nasal reconstruction. 
  • The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity-United States, 2000 to 2006. 
  • The identification and mapping of melanoma regional nodal metastases: minimally invasive surgery for the diagnosis of nodal metastases. 
  • The impact of shave biopsy on the management of patients with thin melanomas. 
  • The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic. 
  • The impact of transplant rejection on cutaneous squamous cell carcinoma in renal transplant recipients. 
  • The incidences of chondritis and perichondritis associated with the surgical manipulation of auricular cartilage. 
  • The influence of history on interobserver agreement for diagnosing actinic keratoses and malignant skin lesions. 
  • The lateral ala's volume and position are critical determinants of aesthetically successful nasal reconstruction: a photographic case series. 
  • The long-term clinical course of patients with cutaneous melanoma. 
  • The management of congenital nevocytic nevi. 
  • The melanoma epidemic. Is increased surveillance the solution or the problem? 
  • The melanoma epidemic: more apparent than real? 
  • The nature and significance of differential keratin gene expression. 
  • The orderly progression of melanoma nodal metastases. 
  • The pathology of extracranial scalp and skull masses in young children. 
  • The prevalence and characteristics of congenital pigmented lesions in newborn babies in Oxford. 
  • The reconstruction of the nasal ala with interpolated flaps from the cheek and forehead: design and execution modifications to improve surgical outcomes. 
  • The relationship between blood IL-12p40 level and melanoma progression. 
  • The role for interleukin-12 therapy of cutaneous T cell lymphoma. 
  • The role of elective lymph node dissection in the management of patients with thick cutaneous melanoma. 
  • The role of resection in the management of melanoma metastatic to the adrenal gland. 
  • The role of surgery for patients with metastatic melanoma. 
  • The role of whole brain radiation therapy in the management of melanoma brain metastases. 
  • The study of nevi in British twins: study design and description of the data set. 
  • The surgical management of metastatic melanoma. 
  • The triangular intermuscular space as a site of lymph node metastasis in melanoma of the back. 
  • The tumor biology of melanoma nodal metastases. 
  • The tumor dormant state. 
  • Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial. 
  • Therapeutic and prognostic considerations of head and neck melanoma. 
  • Therapy with orally administered methoxsalen and ultraviolet A radiation during childhood increases the risk of basal cell carcinoma. The PUVA Follow-up Study. 
  • Thin melanomas: predictive lethal characteristics from a 30-year clinical experience. 
  • Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma. 
  • Time trends of incidence of age-associated diseases in the US elderly population: Medicare-based analysis. 
  • Timing and Number of Cutaneous Squamous Cell Carcinomas in Transplant Recipients. 
  • To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesions. 
  • Tolerability of high-dose topical tretinoin: the Veterans Affairs Topical Tretinoin Chemoprevention Trial. 
  • Topical and oral administration of the natural water-soluble antioxidant from spinach reduces the multiplicity of papillomas in the Tg.AC mouse model. 
  • Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides. 
  • Topical tretinoin therapy and all-cause mortality. 
  • Training High-Volume Melanoma Surgeons to Perform a Novel Minimally Invasive Inguinal Lymphadenectomy: Report of a Prospective Multi-Institutional Trial. 
  • Trametinib (GSK1120212) in the treatment of melanoma. 
  • Transduction of human melanoma cells with interleukin-2 gene reduces tumorigenicity and enhances host antitumor immunity: a nude mouse model. 
  • Transected thin melanoma: Implications for sentinel lymph node staging. 
  • Treatment of cutaneous T cell lymphoma with 2'-deoxycoformycin (pentostatin). 
  • Treatment of cutaneous granulocytic sarcoma in a patient with myelodysplasia. 
  • Treatment of in-transit melanoma: an opportunity to discover critical knowledge. 
  • Treatment of lymphangioma circumscriptum with tunable dye laser. 
  • Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccines. 
  • Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial. 
  • Trichoblastic carcinosarcoma: A case report and literature review. 
  • Tumor cell sensitivity to vemurafenib can be predicted from protein expression in a BRAF-V600E basket trial setting. 
  • Tumor necrosis factor receptor 1/c-Jun-NH2-kinase signaling promotes human neoplasia. 
  • Tumor-induced reshuffling of lipid composition on the endoplasmic reticulum membrane sustains macrophage survival and pro-tumorigenic activity. 
  • Tunneled and transposed island flaps in facial reconstructive surgery. 
  • Two-day lymphoscintigraphic imaging for melanoma. 
  • Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma. 
  • Type of Organ Transplanted Impacts the Risk and Presentation of Cutaneous Squamous Cell Carcinoma in Transplant Recipients. 
  • UBE2N Promotes Melanoma Growth via MEK/FRA1/SOX10 Signaling. 
  • Ultraviolet light and free radicals: an immunologic theory of epidermal carcinogenesis. 
  • Underlying mechanisms of change in cancer prevalence in older U.S. adults: contributions of incidence, survival, and ascertainment at early stages. 
  • United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic. 
  • Unraveling the molecular nature of melanin changes in metastatic cancer 
  • Up-Regulation of PARP1 Expression Significantly Correlated with Poor Survival in Mucosal Melanomas. 
  • Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. 
  • Updates in adjuvant systemic therapy for melanoma. 
  • Updates on Merkel Cell Carcinoma. 
  • Urokinase plasminogen activator is immunocytochemically detectable in squamous cell but not basal cell carcinomas. 
  • Use of integrative epigenetic and cytogenetic analyses to identify novel tumor-suppressor genes in malignant melanoma. 
  • Using a continuous transformation of the Breslow thickness for prognosis in cutaneous melanoma. 
  • Utilization and rationale for the implementation of total body (digital) photography as an adjunct screening measure for melanoma. 
  • Utilization of Indocyanine Green to Aid in Identifying Sentinel Lymph Nodes in Merkel Cell Cancer. 
  • Uveal melanocytomas: genetic comparison with uveal and dermal melanomas. 
  • Validation and comparison of quality-of-life measures for topical 5-fluorouracil treatment: results from a randomized controlled trial. 
  • Validation of delayed sentinel lymph node mapping for melanoma. 
  • Value of frozen-section analysis of sentinel lymph nodes for primary cutaneous malignant melanoma. 
  • Variants in melanocortin 1 receptor gene contribute to risk of melanoma--a direct sequencing analysis in a Texas population. 
  • Variations in the ganglioside profile of uveal melanoma correlate with cytologic heterogeneity. 
  • Vitamin D levels, dietary intake, and photoprotective behaviors among patients with skin cancer. 
  • Vitamin supplementation and reduced risk of basal cell carcinoma. 
  • Vulvar Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma. 
  • What is your diagnosis? Spitzoid melanoma. 
  • What's new in pediatric melanoma: An update from the APSA cancer committee. 
  • White Paper on Ophthalmic Imaging for Choroidal Nevus Identification and Transformation into Melanoma. 
  • Zosteriform lentiginous nevus. 
  • [Adjuvant therapy of surgically removed stage I melanoma]. 
  • [Malignant melanoma: hepatic intra-arterial chemotherapy]. 
  • [Plastic surgery coverage of skin defects]. 
  • alpha-Melanocyte-stimulating hormone-induced eruptive nevi. 
  • c-Jun promotes whereas JunB inhibits epidermal neoplasia. 
  • cDNA arrays and the enigma of melanoma immune responsiveness. 
  • p53 codon 72 Arg homozygotes are associated with an increased risk of cutaneous melanoma. 
  • p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase. 
• 

  Keywords of People

  • Chen, Jun, Professor of Medicine, Duke Cancer Institute
  • Hogan, Brigid L. M., Research Professor of Cell Biology, Cell Biology
  • Lee, Walter T, Professor of Head and Neck Surgery & Communication Sciences, Radiation Oncology
  • Mruthyunjaya, Prithvi, Adjunct Associate Professor in the Department of Ophthalmology, Ophthalmology, Vitreoretinal Diseases & Surgery
  • Sampson, John Howard, Robert H., M.D. and Gloria Wilkins Professor of Neurosurgery, in the School of Medicine, Biomedical Engineering
  • Stoecker, Maggie Marie, Assistant Professor of Pathology, Pathology
  • Sullivan, Daniel Carl, Professor Emeritus of Radiology, Radiology
  • Weinhold, Kent James, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Integrative Immunobiology